Cherry Hill Sales Recalls Clotrimazole Antifungal Cream Due to CGMP Deviations
Cherry Hill Sales Co. is voluntarily recalling 2,400 cartons of MakeSense PHARMA ANTIFUNGAL CREAM due to CGMP deviations. The product was distributed in five states.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, which typically involves a reasonable probability of temporary or medically reversible health consequences. The source cites CGMP deviations without reporting specific illnesses or injuries, aligning with the Moderate severity criteria for voluntary precautionary recalls.
Plain-English summary
Cherry Hill Sales Co. is voluntarily recalling 2,400 cartons of MakeSense PHARMA ANTIFUNGAL CREAM, Clotrimazole 1%, 1.25 oz. (35 g) tube. The product is identified by Lot # 103803, NDC 69020-203-35, and UPC 857181005023, with an expiration date of 08/17. The recall was initiated on January 27, 2017, and was classified as Class II by the FDA.
The reason for the recall is cited as Current Good Manufacturing Practice (CGMP) deviations. The product was made in China and distributed by Cherry Hill Associates in Chesapeake, VA. The affected units were distributed in Michigan, Illinois, New York, Florida, and Pennsylvania.
Consumers with this product should stop using it and contact Cherry Hill Sales Co. for instructions on return or disposal. The recall status is listed as Terminated as of April 19, 2017.
The recalled product
- Product
- MakeSense PHARMA ANTIFUNGAL CREAM Clotrimazole 1%, 1.25 oz. (35 g) tube, Made in China, Distributed by Cherry Hill Associates, Chesapeake, VA 23320, NDC 69020-203-35
- Manufacturer
- Cherry Hill Sales Co.
- Category
- Drug — Topical Antifungal
- Hazard
- Affected units
- 2,400
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot # 103803
- Exp. 08/17 NDC 69020-203-35 UPC 857181005023
Distribution
Part of a larger recall action
This product is one of 5 recalled by Cherry Hill Sales Co. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 5 products in this recall →Related recalls
Same manufacturer · Cherry Hill Sales Co.
See all →- ModerateCherry Hill Sales Recalls MakeSense Antifungal Cream Due to CGMP Deviations
FDA (Drugs) · 2017-03-01
- ModerateCherry Hill Sales Recalls Hemorrhoidal Cream Due to Manufacturing Deviations
FDA (Drugs) · 2017-03-01
- ModerateCherry Hill Sales Recalls Medicated Anti-Itch Cream Due to CGMP Deviations
FDA (Drugs) · 2017-03-01
- ModerateCherry Hill Sales Recalls MakeSense First Aid Cream Due to CGMP Deviations
FDA (Drugs) · 2017-03-01
Same hazard · cgmp deviations
See all →- ModerateFentanyl Citrate Injectable Solution Recall Due to cGMP Deviations
FDA (Drugs) · 2026-05-06
- ModerateGlenmark Pharmaceuticals Recalls Pravastatin Sodium Tablets 80mg
FDA (Drugs) · 2025-04-16
- ModerateGlenmark Lacosamide 100mg Tablets Recalled for CGMP Deviations
FDA (Drugs) · 2025-04-16
- ModerateDrug Recall: APAP 500 mg Phenyl HCl Tablets for CGMP Deviations
FDA (Drugs) · 2022-02-16
- ModerateMigrenol Caplet Drug Recalled for CGMP Deviations
FDA (Drugs) · 2022-02-16